Ovation Science Inc. Logo

Ovation Science Inc.

OVAT.CN

(1.8)
Stock Price

0,03 CAD

-756.35% ROA

86.07% ROE

-1.84x PER

Market Cap.

1.409.788,00 CAD

-30.37% DER

0% Yield

-625.37% NPM

Ovation Science Inc. Stock Analysis

Ovation Science Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ovation Science Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (425.34%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-1.75x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-26%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

5 ROA

The stock's ROA (-691.93%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Ovation Science Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ovation Science Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Ovation Science Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ovation Science Inc. Revenue
Year Revenue Growth
2017 12.545
2018 96.408 86.99%
2019 302.382 68.12%
2020 750.010 59.68%
2021 224.949 -233.41%
2022 138.154 -62.82%
2023 17.540 -687.65%
2023 61.934 71.68%
2024 168.916 63.33%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ovation Science Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 63.876 100%
2019 80.046 20.2%
2020 130.400 38.62%
2021 83.066 -56.98%
2022 65.272 -27.26%
2023 33.396 -95.45%
2023 8.788 -280.02%
2024 8.260 -6.39%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ovation Science Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 152.729
2018 371.709 58.91%
2019 922.220 59.69%
2020 1.470.823 37.3%
2021 892.312 -64.83%
2022 427.802 -108.58%
2023 410.112 -4.31%
2023 458.479 10.55%
2024 369.956 -23.93%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ovation Science Inc. EBITDA
Year EBITDA Growth
2017 -25.077
2018 -409.689 93.88%
2019 -831.739 50.74%
2020 -1.066.224 21.99%
2021 -800.341 -33.22%
2022 -785.632 -1.87%
2023 -639.300 -22.89%
2023 -764.010 16.32%
2024 -517.716 -47.57%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ovation Science Inc. Gross Profit
Year Gross Profit Growth
2017 30.108
2018 82.491 63.5%
2019 283.934 70.95%
2020 548.022 48.19%
2021 187.995 -191.51%
2022 135.178 -39.07%
2023 12.096 -1017.54%
2023 -251.431 104.81%
2024 -134.436 -87.03%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ovation Science Inc. Net Profit
Year Net Profit Growth
2017 -61.541
2018 -508.404 87.9%
2019 -870.019 41.56%
2020 -1.200.519 27.53%
2021 -2.409.827 50.18%
2022 -795.153 -203.06%
2023 -772.696 -2.91%
2023 -813.149 4.97%
2024 -303.252 -168.14%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ovation Science Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ovation Science Inc. Free Cashflow
Year Free Cashflow Growth
2017 -376.859
2018 -382.918 1.58%
2019 -984.569 61.11%
2020 -1.520.330 35.24%
2021 -885.752 -71.64%
2022 -670.803 -32.04%
2023 -336.023 -99.63%
2023 -65.255 -414.94%
2024 -98.207 33.55%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ovation Science Inc. Operating Cashflow
Year Operating Cashflow Growth
2017 -59.931
2018 -382.918 84.35%
2019 -952.901 59.82%
2020 -1.385.147 31.21%
2021 -885.752 -56.38%
2022 -670.803 -32.04%
2023 -336.023 -99.63%
2023 -65.255 -414.94%
2024 -98.207 33.55%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ovation Science Inc. Capital Expenditure
Year Capital Expenditure Growth
2017 316.928
2018 0 0%
2019 31.668 100%
2020 135.183 76.57%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ovation Science Inc. Equity
Year Equity Growth
2017 565.411
2018 2.189.439 74.18%
2019 1.477.599 -48.18%
2020 3.108.350 52.46%
2021 706.155 -340.18%
2022 -82.952 951.28%
2023 -703.717 88.21%
2023 -652.104 -7.91%
2024 -835.226 21.92%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ovation Science Inc. Assets
Year Assets Growth
2017 899.317
2018 2.725.280 67%
2019 1.839.835 -48.13%
2020 3.251.733 43.42%
2021 769.896 -322.36%
2022 104.886 -634.03%
2023 121.054 13.36%
2023 76.888 -57.44%
2024 84.218 8.7%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ovation Science Inc. Liabilities
Year Liabilities Growth
2017 333.906
2018 535.841 37.69%
2019 362.236 -47.93%
2020 143.383 -152.64%
2021 63.741 -124.95%
2022 187.838 66.07%
2023 824.771 77.23%
2023 728.992 -13.14%
2024 919.444 20.71%

Ovation Science Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.02
Price to Earning Ratio
-1.84x
Price To Sales Ratio
13.84x
POCF Ratio
-2.99
PFCF Ratio
-3.59
Price to Book Ratio
-1.41
EV to Sales
16.24
EV Over EBITDA
-2.5
EV to Operating CashFlow
-4.22
EV to FreeCashFlow
-4.22
Earnings Yield
-0.54
FreeCashFlow Yield
-0.28
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.12
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
0.62
ROE
0.86
Return On Assets
-7.56
Return On Capital Employed
0.84
Net Income per EBT
1
EBT Per Ebit
0.96
Ebit per Revenue
-6.52
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
4.63
Research & Developement to Revenue
-0.13
Stock Based Compensation to Revenue
0.37
Gross Profit Margin
-1.5
Operating Profit Margin
-6.52
Pretax Profit Margin
-6.25
Net Profit Margin
-6.25

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
1.16
Return on Tangible Assets
-7.56
Days Sales Outstanding
152.16
Days Payables Outstanding
303.8
Days of Inventory on Hand
40.5
Receivables Turnover
2.4
Payables Turnover
1.2
Inventory Turnover
9.01
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,03
Tangible Book Value per Share
-0.03
Shareholders Equity per Share
-0.03
Interest Debt per Share
0.01
Debt to Equity
-0.3
Debt to Assets
3.01
Net Debt to EBITDA
-0.37
Current Ratio
0.1
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-792239
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
28542
Debt to Market Cap
0.18

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ovation Science Inc. Dividends
Year Dividends Growth

Ovation Science Inc. Profile

About Ovation Science Inc.

Ovation Science Inc. engages in the production of cannabis or hemp products in Canada, the United States, and Mexico. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin care products containing hemp seed oil and cannabis under the Ovation and BASKiN brands. It offers cannabidiol infused health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name. The company holds sublicenses for cannabis based products; and Lighthouse for licensed dispensaries in the United States. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

CEO
Mr. Terry H. Howlett
Employee
0
Address
625 Howe street
Vancouver, V6C 2T6

Ovation Science Inc. Executives & BODs

Ovation Science Inc. Executives & BODs
# Name Age
1 Mr. Terry H. Howlett
President, Chief Executive Officer & Director
70
2 Ms. Doreen McMorran
Chief Financial Officer, Vice President, Chief Operating Officer & Director
70

Ovation Science Inc. Competitors